As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA clearance ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Quest Diagnostics announced that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback